{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:20:59Z","timestamp":1791055259444,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s11033-023-08249-z","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T16:03:18Z","timestamp":1674921798000},"page":"3249-3257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Expression of pro-inflammatory cytokines (IL-6 & IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population"],"prefix":"10.1007","volume":"50","author":[{"given":"Maha","family":"Maqsood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-2380","authenticated-orcid":false,"given":"Saima","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shagufta","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnim","family":"Farasat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farkhanda","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maqsood","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"8249_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpmed.2018.10.002","author":"AM Egan","year":"2019","unstructured":"Egan AM, Dinneen SF (2019) What is diabetes? Medicine. https:\/\/doi.org\/10.1016\/j.mpmed.2018.10.002","journal-title":"Medicine"},{"key":"8249_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30058-2","author":"C Sudesna","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(17)30058-2","journal-title":"Lancet"},{"key":"8249_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/948417","author":"J Donate-Correa","year":"2015","unstructured":"Donate-Correa J, Mart\u00edn-N\u00fa\u00f1ez E, Muros-de-Fuentes M, Mora-Fern\u00e1ndez C, Navarro-Gonz\u00e1lez JF (2015) Inflammatory cytokines in diabetic nephropathy. J Diabetes Res. https:\/\/doi.org\/10.1155\/2015\/948417","journal-title":"J Diabetes Res"},{"key":"8249_CR4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007091048","author":"JF Navarro-Gonzalez","year":"2008","unstructured":"Navarro-Gonzalez JF, Mora-Fernandez C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2007091048","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"8249_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2669\/pjms.333.12537","volume":"33","author":"T Ahmad","year":"2017","unstructured":"Ahmad T, Ulhaq I, Mawani M, Islam N (2017) Microalbuminuria in Type-2 Diabetes Mellitus; the tip of iceberg of diabetic complications. Pakistan J Med Sci 33(3):519. https:\/\/doi.org\/10.2669\/pjms.333.12537","journal-title":"Pakistan J Med Sci"},{"key":"8249_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.04.029","author":"AH Sprague","year":"2009","unstructured":"Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2009.04.029","journal-title":"Biochem pharmacol"},{"issue":"5","key":"8249_CR7","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.1002\/jcp.27427","volume":"234","author":"H Yaribeygi","year":"2019","unstructured":"Yaribeygi H, Atkin SL, Sahebkar A (2019) Interleukin-18 and diabetic nephropathy: a review. J Cell Physiol 234(5):5674\u20135682. https:\/\/doi.org\/10.1002\/jcp.27427","journal-title":"J Cell Physiol"},{"issue":"11","key":"8249_CR8","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/medicina58111604","volume":"58","author":"G Mansoor","year":"2022","unstructured":"Mansoor G, Tahir M, Maqbool T, Abbasi Q, Hadi F, Shakoori TA, Ullah I (2022) Increased expression of circulating stress markers, inflammatory cytokines and decreased antioxidant level in diabetic nephropathy. Medicina 58(11):1604. https:\/\/doi.org\/10.3390\/medicina58111604","journal-title":"Medicina"},{"key":"8249_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/146154","author":"AK Lim","year":"2012","unstructured":"Lim AK, Tesch GH (2012) Inflammation in diabetic nephropathy. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2012\/146154","journal-title":"Mediators Inflamm"},{"key":"8249_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.628289","author":"J Donate-Correa","year":"2021","unstructured":"Donate-Correa J, Ferri CM, S\u00e1nchez-Quintana F, P\u00e9rez-Castro A, Gonz\u00e1lez-Luis A, Mart\u00edn-N\u00fa\u00f1e E, Mora-Fern\u00e1ndez C, Navarro-Gonz\u00e1lez JF (2021) Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications. Front Med. https:\/\/doi.org\/10.3389\/fmed.2020.628289","journal-title":"Front Med"},{"key":"8249_CR11","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1101\/pdb.prot5439","volume":"6","author":"DC Rio","year":"2010","unstructured":"Rio DC, Ares M, Hannon GJ, Nilsen TW (2010) Purification of RNA using TRIzol (TRI reagent). Cold Spring Harbor Protoc 6:5439. https:\/\/doi.org\/10.1101\/pdb.prot5439","journal-title":"Cold Spring Harbor Protoc"},{"issue":"3","key":"8249_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","volume":"5","author":"MB Duran-Salgado","year":"2014","unstructured":"Duran-Salgado MB, Rubio-Guerra AF (2014) Diabetic nephropathy and inflammation. World J Diabetes 5(3):393. https:\/\/doi.org\/10.4239\/wjd.v5.i3.393","journal-title":"World J Diabetes"},{"key":"8249_CR13","doi-asserted-by":"publisher","DOI":"10.5772\/34541","author":"V Lopez-Parra","year":"2012","unstructured":"Lopez-Parra V, Mallavia B, Egido J, Gomez-Guerrero C (2012) Immunoinflammation in diabetic nephropathy: molecular mechanisms and therapeutic options. Diabetic Nephrop. https:\/\/doi.org\/10.5772\/34541","journal-title":"Diabetic Nephrop"},{"key":"8249_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(21)00177-X","author":"T Wang","year":"2021","unstructured":"Wang T, Zhao Z, Wang G, Li Q, Xu Y, Li M, Hu R, Chen G, Su Q, Mu Y, Tang X (2021) Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study. Lancet Healthy Long. https:\/\/doi.org\/10.1016\/S2666-7568(21)00177-X","journal-title":"Lancet Healthy Long"},{"key":"8249_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088956","author":"K Al-Rubeaan","year":"2014","unstructured":"Al-Rubeaan K, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, Al-Mutlaq HM, David SK, AlNaqeb D (2014) Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PloS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0088956","journal-title":"PloS ONE"},{"issue":"3","key":"8249_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/hpm.2871","volume":"34","author":"J Lou","year":"2019","unstructured":"Lou J, Jing L, Yang H, Qin F, Long W, Shi R (2019) Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: logistic regression and classification tree model analysis. Int J Health Plann Manage 34(3):1013\u20131024. https:\/\/doi.org\/10.1002\/hpm.2871","journal-title":"Int J Health Plann Manage"},{"key":"8249_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2147\/IJGM.S255858","volume":"13","author":"F Hu","year":"2020","unstructured":"Hu F, Zhang T (2020) Study on risk factors of diabetic nephropathy in obese patients with type 2 diabetes mellitus. Int J Gen Med 13:351. https:\/\/doi.org\/10.2147\/IJGM.S255858","journal-title":"Int J Gen Med"},{"issue":"1","key":"8249_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-14-6","volume":"14","author":"HM Chen","year":"2013","unstructured":"Chen HM, Shen WW, Ge YC, Zhang YD, Xie HL, Liu ZH (2013) The relationship between obesity and diabetic nephropathy in China. BMC Nephrol 14(1):1\u20139. https:\/\/doi.org\/10.1186\/1471-2369-14-6","journal-title":"BMC Nephrol"},{"key":"8249_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6353949","author":"N Nata","year":"2020","unstructured":"Nata N, Rangsin R, Supasyndh O, Satirapoj B (2020) Impaired glomerular filtration rate in type 2 diabetes mellitus subjects: a nationwide cross-sectional study in Thailand. J Diabetes Res. https:\/\/doi.org\/10.1155\/2020\/6353949","journal-title":"J Diabetes Res"},{"issue":"5","key":"8249_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4239\/wjd.v5.i5.697","volume":"5","author":"NK Agrawal","year":"2014","unstructured":"Agrawal NK, Kant S (2014) Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes 5(5):697. https:\/\/doi.org\/10.4239\/wjd.v5.i5.697","journal-title":"World J Diabetes"},{"key":"8249_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154832","author":"R Fadaei","year":"2020","unstructured":"Fadaei R, Bagheri N, Heidarian E, Nouri A, Hesari Z, Moradi N, Ahmadi A, Ahmadi R (2020) Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-\u03b1 and IL-6. Cytokine. https:\/\/doi.org\/10.1016\/j.cyto.2019.154832","journal-title":"Cytokine"},{"issue":"1","key":"8249_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00738-1","volume":"21","author":"B Ayelign","year":"2021","unstructured":"Ayelign B, Negash M, Andualem H, Wondemagegn T, Kassa E, Shibabaw T, Akalu Y, Molla MD (2021) Association of IL-10 (\u2212 1082 A\/G) and IL-6 (\u2212 174 G\/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population. BMC Endocr Disord 21(1):1\u20138. https:\/\/doi.org\/10.1186\/s12902-021-00738-1","journal-title":"BMC Endocr Disord"},{"key":"8249_CR23","doi-asserted-by":"publisher","unstructured":"Bashir H, Bhat SA, Majid S, Hamid R, Koul RK, Rehman MU, Din I, Bhat JA, Qadir J, Masood A (2020). Role of inflammatory mediators (TNF-\u03b1, IL-6, CRP) biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir India. Medical journal of the Islamic Republic of Iran. https:\/\/doi.org\/10.34171\/mjiri.34.5","DOI":"10.34171\/mjiri.34.5"},{"issue":"4","key":"8249_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.bbrc.2007.06.002","volume":"359","author":"ZF Lu","year":"2007","unstructured":"Lu ZF, Doulabi BZ, Wuisman PI, Bank RA, Helder MN (2007) Differentiation of adipose stem cells by nucleus pulposus cells: configuration effect. Biochem Biophy Res Commun 359(4):991\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2007.06.002","journal-title":"Biochem Biophy Res Commun"},{"issue":"8","key":"8249_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"21","author":"H Su","year":"2017","unstructured":"Su H, Lei CT, Zhang C (2017) Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol 21(8):405. https:\/\/doi.org\/10.3389\/fimmu.2017.00405","journal-title":"Front Immunol"},{"issue":"7","key":"8249_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/08820139.2018.1480031","volume":"47","author":"M Akbari","year":"2018","unstructured":"Akbari M, Hassan-Zadeh V (2018) Hyperglycemia affects the expression of inflammatory genes in peripheral blood mononuclear cells of patients with type 2 diabetes. Immunol Investig 47(7):654\u201365. https:\/\/doi.org\/10.1080\/08820139.2018.1480031","journal-title":"Immunol Investig"},{"issue":"1","key":"8249_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.dsx.2018.11.022","volume":"13","author":"T Sueud","year":"2019","unstructured":"Sueud T, Hadi NR, Abdulameer R, Jamil DA, Al-Aubaidy HA (2019) Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy. diabetes & metabolic syndrome. Clin Res Rev 13(1):564\u20138. https:\/\/doi.org\/10.1016\/j.dsx.2018.11.022","journal-title":"Clin Res Rev"},{"issue":"3","key":"8249_CR28","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/j.diabres.2011.02.028","volume":"92","author":"T Fujita","year":"2011","unstructured":"Fujita T, Shimizu C, Fuke Y, Satomura A, Abe M, Kaizu K, Soma M (2011) Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. Diab Res Clin Pract 92(3):e66\u2013e69. https:\/\/doi.org\/10.1016\/j.diabres.2011.02.028","journal-title":"Diab Res Clin Pract"},{"issue":"3","key":"8249_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1042\/CS20120198","volume":"124","author":"J Wada","year":"2013","unstructured":"Wada J, Makino H (2013) Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci 124(3):139\u2013152. https:\/\/doi.org\/10.1042\/CS20120198","journal-title":"Clin Sci"},{"issue":"1","key":"8249_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40620-014-0113-9","volume":"28","author":"X Lin","year":"2015","unstructured":"Lin X, Yuan J, Zhao Y, Zha Y (2015) Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis. J Nephrol 28(1):7\u201316. https:\/\/doi.org\/10.1007\/s40620-014-0113-9","journal-title":"J Nephrol"},{"issue":"1","key":"8249_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-42661-5","volume":"9","author":"N Tsutsumi","year":"2019","unstructured":"Tsutsumi N, Yokota A, Kimura T, Kato Z, Fukao T, Shirakawa M, Tochio H (2019) An innate interaction between IL-18 and the propeptide that inactivates its precursor form. Sci Rep 9(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-019-42661-5","journal-title":"Sci Rep"},{"key":"8249_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8032797","author":"K Chi","year":"2020","unstructured":"Chi K, Geng X, Liu C, Cai G, Hong Q (2020) Research progress on the role of inflammasomes in kidney disease. Med Inflamm. https:\/\/doi.org\/10.1155\/2020\/8032797","journal-title":"Med Inflamm"},{"issue":"1","key":"8249_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12610-022-00157-9","volume":"32","author":"M Tavalae","year":"2022","unstructured":"Tavalae M, Rahmani M, Drevet JR, Nasr-Esfahani MH (2022) The NLRP3 inflammasome: molecular activation and regulation in spermatogenesis and male infertility; a systematic review. Basic Clin Androl 32(1):1\u201311. https:\/\/doi.org\/10.1186\/s12610-022-00157-9","journal-title":"Basic Clin Androl"},{"issue":"4","key":"8249_CR34","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/jcb.26450","volume":"119","author":"H Yaribeygi","year":"2018","unstructured":"Yaribeygi H, Farrokhi FR, Rezaee R, Sahebkar A (2018) Oxidative stress induces renal failure: a review of possible molecular pathways. J Cell Biochem 119(4):2990\u20132998. https:\/\/doi.org\/10.1002\/jcb.26450","journal-title":"J Cell Biochem"},{"issue":"6","key":"8249_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4239\/wjd.v8.i6.304","volume":"8","author":"SS Fatima","year":"2017","unstructured":"Fatima SS, Jamil Z, Abidi SH, Nadeem D, Bashir Z, Ansari A (2017) Interleukin 18 polymorphism as an inflammatory index in metabolic syndrome a preliminary study. World J Diabetes 8(6):304. https:\/\/doi.org\/10.4239\/wjd.v8.i6.304","journal-title":"World J Diabetes"},{"issue":"9","key":"8249_CR36","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/ijo.2008.109","volume":"32","author":"GR Zilverschoon","year":"2008","unstructured":"Zilverschoon GR, Tack CJ, Joosten LA, Kullberg BJ, Van Der Meer JW, Netea MG (2008) Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes 32(9):1407\u20131414. https:\/\/doi.org\/10.1038\/ijo.2008.109","journal-title":"Int J Obes"},{"issue":"75","key":"8249_CR37","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","volume":"1","author":"NL Edwards","year":"2008","unstructured":"Edwards NL (2008) The role of hyperuricemia and gout in kidney and cardiovascular disease. Clevel Clin J Med 1(75):S13\u2013S16. https:\/\/doi.org\/10.3949\/ccjm.75.Suppl_5.S13","journal-title":"Clevel Clin J Med"},{"issue":"5","key":"8249_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.semnephrol.2011.08.011","volume":"31","author":"DI Jalal","year":"2011","unstructured":"Jalal DI, Maahs DM, Hovind P, Nakagawa T (2011) Uric acid as a mediator of diabetic nephropathy. InSeminars Nephrol 31(5):459\u2013465. https:\/\/doi.org\/10.1016\/j.semnephrol.2011.08.011","journal-title":"InSeminars Nephrol"},{"issue":"7\u20138","key":"8249_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.repce.2012.05.003","volume":"31","author":"S Barra","year":"2012","unstructured":"Barra S, Provid\u00eancia R, Silva J, Gomes PL, Seca L, Nascimento J, Leit\u00e3o-Marques A (2012) Glomerular filtration rate: which formula should be used in patients with myocardial infarction? Rev Port Cardiol 31(7\u20138):493\u2013502. https:\/\/doi.org\/10.1016\/j.repce.2012.05.003","journal-title":"Rev Port Cardiol"},{"key":"8249_CR40","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.7(3)2015.27233","author":"OSP Sah","year":"2015","unstructured":"Sah OSP, Qing YX (2015) Associations between hyperuricemia and chronic kidney disease: a review. Nephro Urol Month. https:\/\/doi.org\/10.5812\/numonthly.7(3)2015.27233","journal-title":"Nephro Urol Month"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08249-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T15:44:50Z","timestamp":1679931890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08249-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["8249"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08249-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethical Review Committee of Lahore College for Women University, Lahore. (No. REF\/NO\/LCWU\/ZOO\/586-; Dated: 18-01-2019). We also received IRB approval letter from Shaikh Zayed Medical Complex, Lahore (IRB ID: SZMC\/IRB\/Internal\/265\/2020). We received permission letter of blood sampling from Civil Hospital. Karachi (REF NO: 12449; Date: 16-11-2020) and DHQ, Hospital for Gujranwala (Memo # 21; Date: 27-7-2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Prior to their participation, all of the participants gave their informed consent, and the data were either pseudonymized or anonymized, depending on the circumstance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors state that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}